Title: MATE Act of 2021
Policy area: Health

Summary:
Medication Access and Training Expansion Act of 2021 or the MATE Act of 2021
This bill requires health care providers, as a condition of receiving or renewing a registration to prescribe potentially addictive drugs, to complete a one-time training on managing patients with substance use disorders.
In addition, the Department of Health and Human Services must award grants to health professional associations and education programs for integrating substance use disorder training into relevant curricula.

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2067 Introduced in House (IH)]

<DOC>






117th CONGRESS
  1st Session
                                H. R. 2067

To amend the Controlled Substances Act to require physicians and other 
 prescribers of controlled substances to complete training on treating 
 and managing patients with opioid and other substance use disorders, 
                        and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             March 18, 2021

  Mrs. Trahan (for herself, Mr. Carter of Georgia, Mr. McKinley, Ms. 
Kuster, Mr. Trone, and Mr. Tonko) introduced the following bill; which 
 was referred to the Committee on Energy and Commerce, and in addition 
  to the Committee on the Judiciary, for a period to be subsequently 
   determined by the Speaker, in each case for consideration of such 
 provisions as fall within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
To amend the Controlled Substances Act to require physicians and other 
 prescribers of controlled substances to complete training on treating 
 and managing patients with opioid and other substance use disorders, 
                        and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Medication Access and Training 
Expansion Act of 2021'' or the ``MATE Act of 2021''.

SEC. 2. REQUIRING PRESCRIBERS OF CONTROLLED SUBSTANCES TO COMPLETE 
              TRAINING ON TREATING AND MANAGING PATIENTS WITH OPIOID 
              AND OTHER SUBSTANCE USE DISORDERS.

    Section 303 of the Controlled Substances Act (21 U.S.C. 823) is 
amended by adding at the end the following:
    ``(l) Required Training for Prescribers on Treating and Managing 
Patients With Opioid and Other Substance Use Disorders.--
            ``(1) Applicability.--This subsection applies--
                    ``(A) with respect to any practitioner who is 
                licensed under State law to prescribe controlled 
                substances and is not a veterinarian or a dentist; and
                    ``(B) beginning with the first registration or 
                renewal of registration by the practitioner under this 
                section occurring 180 or more days after the date of 
                enactment of the Medication Access and Training 
                Expansion Act of 2021.
            ``(2) Training required.--As a condition on registration 
        under this section to dispense controlled substances in 
        schedule II, III, IV, or V, the Attorney General shall require 
        any practitioner described in paragraph (1)(A) to meet the 
        following:
                    ``(A) If the practitioner is a physician, the 
                practitioner must meet one or more of the following 
                conditions:
                            ``(i) The physician holds a board 
                        certification in addiction psychiatry or 
                        addiction medicine from the American Board of 
                        Medical Specialties.
                            ``(ii) The physician holds a board 
                        certification from the American Board of 
                        Addiction Medicine.
                            ``(iii) The physician holds a board 
                        certification in addiction medicine from the 
                        American Osteopathic Association.
                            ``(iv) The physician has, with respect to 
                        the treatment and management of patients with 
                        opioid or other substance use disorders, 
                        completed not less than 8 hours of training 
                        (through classroom situations, seminars at 
                        professional society meetings, electronic 
                        communications, or otherwise) that is provided 
                        by--
                                    ``(I) the American Society of 
                                Addiction Medicine, the American 
                                Academy of Addiction Psychiatry, the 
                                American Medical Association, the 
                                American Osteopathic Association, the 
                                American Psychiatric Association, or 
                                any other organization accredited by 
                                the Accreditation Council for 
                                Continuing Medical Education (commonly 
                                known as the `ACCME');
                                    ``(II) any organization accredited 
                                by a State medical society accreditor 
                                recognized by the ACCME; or
                                    ``(III) any organization accredited 
                                by the American Osteopathic Association 
                                to provide continuing medical 
                                education.
                            ``(v) The physician graduated in good 
                        standing from an accredited school of 
                        allopathic medicine or osteopathic medicine in 
                        the United States during the 5-year period 
                        immediately preceding the date on which the 
                        physician first registers or renews under this 
                        section and has successfully completed a 
                        comprehensive allopathic or osteopathic 
                        medicine curriculum or accredited medical 
                        residency that included not less than 8 hours 
                        of training on treating and managing patients 
                        with opioid and other substance use disorders, 
                        including the appropriate clinical use of all 
                        drugs approved by the Food and Drug 
                        Administration for the treatment of a substance 
                        use disorder.
                    ``(B) If the practitioner is not a physician, the 
                practitioner must meet one or more of the following 
                conditions:
                            ``(i) Completed not fewer than 8 hours of 
                        training with respect to the treatment and 
                        management of patients with opioid or other 
                        substance use disorders (through classroom 
                        situations, seminars at professional society 
                        meetings, electronic communications, or 
                        otherwise) provided by the American Society of 
                        Addiction Medicine, the American Academy of 
                        Addiction Psychiatry, the American Medical 
                        Association, the American Osteopathic 
                        Association, the American Nurses Credentialing 
                        Center, the American Psychiatric Association, 
                        the American Association of Nurse 
                        Practitioners, the American Academy of 
                        Physician Assistants, or any other organization 
                        that the Secretary determines is appropriate 
                        for purposes of this clause.
                            ``(ii) Graduated in good standing from an 
                        accredited physician assistant school or 
                        accredited school of advanced practice nursing 
                        in the United States during the 5-year period 
                        immediately preceding the date on which the 
                        practitioner first registers or renews under 
                        this section and has successfully completed a 
                        comprehensive physician assistant or advanced 
                        practice nursing curriculum that included not 
                        less than 8 hours of training on treating and 
                        managing patients with opioid and other 
                        substance use disorders, including the 
                        appropriate clinical use of all drugs approved 
                        by the Food and Drug Administration for the 
                        treatment of a substance use disorder.
            ``(3) One-time training.--The Attorney General shall not 
        require any practitioner to complete the training described in 
        clause (iv) or (v) of paragraph (2)(A) or clause (i) or (ii) of 
        paragraph (2)(B) more than once.
            ``(4) Rule of construction.--Nothing in this subsection 
        shall be construed to prevent a practitioner from using the 
        same training both for purposes of satisfying the registration 
        requirement of this subsection and for other purposes, such as 
        satisfying State licensing requirements.''.

SEC. 3. PRACTITIONER EDUCATION GRANT PROGRAM.

    Title V of the Public Health Service Act is amended by inserting 
after section 509 of such Act (42 U.S.C. 290bb-2) the following:

``SEC. 510. PRACTITIONER EDUCATION GRANT PROGRAM.

    ``(a) In General.--The Secretary shall carry out a program to award 
grants to eligible entities to expand the integration of substance use 
disorder education into the standard curriculum of relevant health care 
and health services education programs, thereby expanding the number of 
practitioners who deliver high-quality, evidence-based substance use 
disorder treatment.
    ``(b) Eligible Entities.--To be eligible to receive a grant under 
this section, an entity shall be--
            ``(1) a private nonprofit or public professional 
        association representing health care professionals in the field 
        of medicine, physician assistants, nursing, social work, 
        psychology, marriage and family therapy, or health services 
        administration; or
            ``(2) a private nonprofit or public entity that is a 
        university, college, or other professional school.
    ``(c) Authorization of Appropriations.--To carry out this section, 
there is authorized to be appropriated such sums as may be necessary 
for each of fiscal years 2022 through 2027.''.
                                 <all>